A

Arcellx Inc
NASDAQ:ACLX

Watchlist Manager
Arcellx Inc
NASDAQ:ACLX
Watchlist
Price: 65.14 USD 5.18% Market Closed
Market Cap: 3.6B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+84%
Revenue
Forecast
N/A
Operating Income
Forecast
+73%
Net Income
Forecast
N/A

Wall Street
Price Targets

ACLX Price Targets Summary
Arcellx Inc

Wall Street analysts forecast ACLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACLX is 113.76 USD with a low forecast of 93.93 USD and a high forecast of 140.7 USD.

ACLX Lowest Forecast
Wall Street Target
93.93 USD
44% Upside
ACLX Average Forecast
Wall Street Target
113.76 USD
75% Upside
ACLX Highest Forecast
Wall Street Target
140.7 USD
116% Upside
Lowest
Price Target
93.93 USD
44% Upside
Average
Price Target
113.76 USD
75% Upside
Highest
Price Target
140.7 USD
116% Upside
Arcellx Inc Competitors:
Price Targets
BCYC
Bicycle Therapeutics PLC
227% Upside
J
7774
Japan Tissue Engineering Co Ltd
100% Upside
PRTC
PureTech Health PLC
250% Upside
AVTE
Aerovate Therapeutics Inc
11% Downside
BCYC
Bicycle Therapeutics PLC
227% Upside
J
7774
Japan Tissue Engineering Co Ltd
100% Upside
PRTC
PureTech Health PLC
250% Upside
AVTE
Aerovate Therapeutics Inc
11% Downside
K
2162
KeyMed Biosciences Inc
36% Upside
S
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
16% Downside
BMRN
Biomarin Pharmaceutical Inc
73% Upside
VLA
Valneva SE
171% Upside

Revenue
Forecast

Revenue Estimate
Arcellx Inc

The compound annual growth rate of Arcellx Inc's revenue for the next 3 years is 34%.

N/A
Past Growth
34%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Arcellx Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Arcellx Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
What are analyst estimates?

See Also

Summary
ACLX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ACLX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ACLX stock valuation using valuation multiples.
Wall Street Estimates
ACLX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ACLX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACLX's stock price target?
Price Target
113.76 USD

According to Wall Street analysts, the average 1-year price target for ACLX is 113.76 USD with a low forecast of 93.93 USD and a high forecast of 140.7 USD.

What is Arcellx Inc's Revenue forecast?
Projected CAGR
34%

The compound annual growth rate of Arcellx Inc's revenue for the next 3 years is 34%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 259,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.